-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Biora Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2019 to Q1 2022.
- Biora Therapeutics, Inc. Selling and Marketing Expense for the quarter ending March 31, 2022 was $13.5M, a 32.6% decline year-over-year.
- Biora Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending March 31, 2022 was -$1.74M, a 115% decline year-over-year.
- Biora Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $4.76M, a 20% decline from 2020.
- Biora Therapeutics, Inc. annual Selling and Marketing Expense for 2020 was $5.95M, a 89.9% decline from 2019.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)